Fiji’s healthcare system struggles with soaring treatment costs and the challenge of offering suitable care for patients with complex conditions....

TUESDAY, Aug. 12, 2025 -- Metformin use is associated with lower risks for dementia and all-cause mortality across body mass index (BMI) groups in...

Gout and type 2 diabetes often coexist, exacerbating metabolic health issues through shared risk factors like obesity and poor diet. Insulin...

Gout and type 2 diabetes often coexist, exacerbating metabolic health issues through shared risk factors like obesity and poor diet. Insulin...

TORONTO — Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes. Between 30 and 50 per...

TORONTO — Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes. Between 30 and 50 per...

Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes. Between 30 and 50 per cent of...

TORONTO — Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes. Between 30 and 50 per...

Fatty liver disease, a growing concern, affects one in three adults globally. Simple dietary errors like consuming excess sugar and processed foods,...

Fatty liver disease, a growing concern, affects one in three adults globally. Simple dietary errors like consuming excess sugar and processed foods,...